P&G Files A Third Suit To Stop Generic Actonel
The complaint, lodged in the U.S. District Court for the District of Delaware, responds to an abbreviated new drug application filed by Teva for a 35 mg form of generic Actonel co-packaged with calcium carbonate tablets.
Procter & Gamble has two other suits pending before the...
To view the full article, register now.
Try Law360 FREE for seven days
Already a subscriber? Click here to login